the role and clinical use of tpo receptor agonists in the treatment of itp
Published 1 year ago • 174 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
1:59
novel investigational drugs and promising therapies for immune thrombocytopenia
-
2:38
the management of itp during and after the covid-19 pandemic
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:11
the therapeutic implications of shared pathophysiology in classical itp and other thrombocytopenias
-
2:29
the role of the multidisciplinary team in providing adequate diagnosis & treatment for bpdcn
-
5:33
low platelets in itp, don’t panic
-
23:49
clinical updates on thrombotic thrombocytopenic purpura (ttp)
-
21:38
drawing the line: the rationale behind blood tube collection order
-
9:50
hemophagocytic lymphohistiocytosis ( hlh) by dr. saurabh taneja | anesthesia residency
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
0:57
zamtocabtagene autoleucel: mechanism of production & potential implications for access
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
1:06
overview of the diagnostic work-up for hemophilia
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml